ID   TOPK_HUMAN              Reviewed;         322 AA.
AC   Q96KB5; B4DX68; D3DST2; Q9NPD9; Q9NYL7; Q9NZK6;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 3.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Lymphokine-activated killer T-cell-originated protein kinase;
DE            EC=2.7.12.2;
DE   AltName: Full=Cancer/testis antigen 84;
DE            Short=CT84;
DE   AltName: Full=MAPKK-like protein kinase;
DE   AltName: Full=Nori-3;
DE   AltName: Full=PDZ-binding kinase;
DE   AltName: Full=Spermatogenesis-related protein kinase;
DE            Short=SPK;
DE   AltName: Full=T-LAK cell-originated protein kinase;
GN   Name=PBK; Synonyms=TOPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, PHOSPHORYLATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Lymphoid tissue;
RX   PubMed=10781613; DOI=10.1074/jbc.M909629199;
RA   Abe Y., Matsumoto S., Kito K., Ueda N.;
RT   "Cloning and expression of a novel MAPKK-like protein kinase,
RT   lymphokine-activated killer T-cell-originated protein kinase,
RT   specifically expressed in the testis and activated lymphoid cells.";
RL   J. Biol. Chem. 275:21525-21531(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION, MUTAGENESIS
RP   OF 64-LEU-LEU-65; THR-320 AND VAL-322, INTERACTION WITH DLG1, AND
RP   VARIANT SER-107.
RX   PubMed=10779557; DOI=10.1073/pnas.090102397;
RA   Gaudet S., Branton D., Lue R.A.;
RT   "Characterization of PDZ-binding kinase, a mitotic kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5167-5172(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT SER-107.
RC   TISSUE=Fetal brain;
RX   PubMed=11378444; DOI=10.1016/S1357-2725(01)00005-X;
RA   Zhao S., Dai J., Zhao W., Xia F., Zhou Z., Wang W., Gu S., Ying K.,
RA   Xie Y., Mao Y.;
RT   "PDZ-binding kinase participates in spermatogenesis.";
RL   Int. J. Biochem. Cell Biol. 33:631-636(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   SER-107.
RC   TISSUE=Embryo, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH TP53, AND MUTAGENESIS OF THR-9.
RX   PubMed=17482142; DOI=10.1016/j.bbrc.2007.04.125;
RA   Nandi A.K., Ford T., Fleksher D., Neuman B., Rapoport A.P.;
RT   "Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase,
RT   involves protein-protein interaction with tumor suppressor p53.";
RL   Biochem. Biophys. Res. Commun. 358:181-188(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-24; SER-32 AND SER-59,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-9; SER-32 AND SER-59, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9 AND SER-59, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-107 AND LEU-241.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates MAP kinase p38. Seems to be active only
CC       in mitosis. May also play a role in the activation of lymphoid
CC       cells. When phosphorylated, forms a complex with TP53, leading to
CC       TP53 destabilization and attenuation of G2/M checkpoint during
CC       doxorubicin-induced DNA damage. {ECO:0000269|PubMed:10781613,
CC       ECO:0000269|PubMed:17482142}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by phosphorylation. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with DLG1 and TP53.
CC       {ECO:0000269|PubMed:10779557, ECO:0000269|PubMed:17482142}.
CC   -!- INTERACTION:
CC       P10398:ARAF; NbExp=3; IntAct=EBI-536853, EBI-365961;
CC       P04637:TP53; NbExp=7; IntAct=EBI-536853, EBI-366083;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96KB5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96KB5-2; Sequence=VSP_055269;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the testis and placenta. In the
CC       testis, restrictedly expressed in outer cell layer of seminiferous
CC       tubules. {ECO:0000269|PubMed:10781613,
CC       ECO:0000269|PubMed:11378444}.
CC   -!- PTM: Phosphorylated; in a cell-cycle dependent manner at mitosis.
CC       {ECO:0000269|PubMed:10779557, ECO:0000269|PubMed:10781613}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB027249; BAA99576.1; -; mRNA.
DR   EMBL; AB027250; BAA99577.1; -; mRNA.
DR   EMBL; AF189722; AAF69107.1; -; mRNA.
DR   EMBL; AF237709; AAF71521.1; -; mRNA.
DR   EMBL; AK027291; BAB55019.1; -; mRNA.
DR   EMBL; AK301836; BAG63280.1; -; mRNA.
DR   EMBL; AC104997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63536.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63537.1; -; Genomic_DNA.
DR   EMBL; BC015191; AAH15191.1; -; mRNA.
DR   CCDS; CCDS6063.1; -. [Q96KB5-1]
DR   CCDS; CCDS64858.1; -. [Q96KB5-2]
DR   RefSeq; NP_001265874.1; NM_001278945.1. [Q96KB5-2]
DR   RefSeq; NP_060962.2; NM_018492.3. [Q96KB5-1]
DR   RefSeq; XP_006716431.1; XM_006716368.2. [Q96KB5-1]
DR   UniGene; Hs.104741; -.
DR   PDB; 5J0A; X-ray; 2.74 A; A=23-320, B=19-319.
DR   PDBsum; 5J0A; -.
DR   ProteinModelPortal; Q96KB5; -.
DR   SMR; Q96KB5; -.
DR   BioGrid; 120971; 30.
DR   IntAct; Q96KB5; 11.
DR   MINT; MINT-130347; -.
DR   STRING; 9606.ENSP00000301905; -.
DR   BindingDB; Q96KB5; -.
DR   ChEMBL; CHEMBL4896; -.
DR   GuidetoPHARMACOLOGY; 2140; -.
DR   iPTMnet; Q96KB5; -.
DR   PhosphoSitePlus; Q96KB5; -.
DR   BioMuta; PBK; -.
DR   DMDM; 83305809; -.
DR   EPD; Q96KB5; -.
DR   PaxDb; Q96KB5; -.
DR   PeptideAtlas; Q96KB5; -.
DR   PRIDE; Q96KB5; -.
DR   DNASU; 55872; -.
DR   Ensembl; ENST00000301905; ENSP00000301905; ENSG00000168078. [Q96KB5-1]
DR   Ensembl; ENST00000522944; ENSP00000428489; ENSG00000168078. [Q96KB5-2]
DR   GeneID; 55872; -.
DR   KEGG; hsa:55872; -.
DR   UCSC; uc011lap.4; human. [Q96KB5-1]
DR   CTD; 55872; -.
DR   DisGeNET; 55872; -.
DR   GeneCards; PBK; -.
DR   HGNC; HGNC:18282; PBK.
DR   HPA; HPA005753; -.
DR   HPA; HPA050656; -.
DR   MIM; 611210; gene.
DR   neXtProt; NX_Q96KB5; -.
DR   OpenTargets; ENSG00000168078; -.
DR   PharmGKB; PA134925802; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00720000108839; -.
DR   HOGENOM; HOG000294208; -.
DR   HOVERGEN; HBG056011; -.
DR   InParanoid; Q96KB5; -.
DR   KO; K08865; -.
DR   OMA; HMARGLK; -.
DR   OrthoDB; EOG091G05V7; -.
DR   PhylomeDB; Q96KB5; -.
DR   TreeFam; TF329763; -.
DR   SignaLink; Q96KB5; -.
DR   SIGNOR; Q96KB5; -.
DR   ChiTaRS; PBK; human.
DR   GeneWiki; PBK_(gene); -.
DR   GenomeRNAi; 55872; -.
DR   PRO; PR:Q96KB5; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000168078; -.
DR   CleanEx; HS_PBK; -.
DR   ExpressionAtlas; Q96KB5; baseline and differential.
DR   Genevisible; Q96KB5; HS.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0007067; P:mitotic nuclear division; NAS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR034368; TOPK.
DR   PANTHER; PTHR43289:SF3; PTHR43289:SF3; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    322       Lymphokine-activated killer T-cell-
FT                                originated protein kinase.
FT                                /FTId=PRO_0000086763.
FT   DOMAIN       32    322       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      38     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      320    322       PDZ-interaction.
FT   ACT_SITE    167    167       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      64     64       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES       9      9       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      24     24       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      59     59       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     198    198       T -> TAPAFITILLVS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055269.
FT   VARIANT     107    107       N -> S (in dbSNP:rs3779620).
FT                                {ECO:0000269|PubMed:10779557,
FT                                ECO:0000269|PubMed:11378444,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_021162.
FT   VARIANT     220    220       E -> D (in dbSNP:rs17057901).
FT                                /FTId=VAR_051676.
FT   VARIANT     241    241       M -> L (in dbSNP:rs36086402).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041234.
FT   MUTAGEN       9      9       T->E: TP53-binding.
FT                                {ECO:0000269|PubMed:17482142}.
FT   MUTAGEN      64     65       KK->AA: Loss of activity.
FT                                {ECO:0000269|PubMed:10779557}.
FT   MUTAGEN     320    320       T->A: Decrease in the binding to DLG1.
FT                                {ECO:0000269|PubMed:10779557}.
FT   MUTAGEN     322    322       V->A: Decrease in the binding to DLG1.
FT                                {ECO:0000269|PubMed:10779557}.
FT   CONFLICT     34     34       F -> I (in Ref. 3; AAF71521).
FT                                {ECO:0000305}.
FT   CONFLICT    169    169       K -> E (in Ref. 4; BAB55019).
FT                                {ECO:0000305}.
FT   CONFLICT    254    254       D -> N (in Ref. 4; BAB55019).
FT                                {ECO:0000305}.
FT   STRAND       26     29       {ECO:0000244|PDB:5J0A}.
FT   HELIX        34     37       {ECO:0000244|PDB:5J0A}.
FT   STRAND       44     48       {ECO:0000244|PDB:5J0A}.
FT   HELIX        54     57       {ECO:0000244|PDB:5J0A}.
FT   HELIX        60     65       {ECO:0000244|PDB:5J0A}.
FT   HELIX        69     71       {ECO:0000244|PDB:5J0A}.
FT   HELIX        73     77       {ECO:0000244|PDB:5J0A}.
FT   STRAND       78     82       {ECO:0000244|PDB:5J0A}.
FT   HELIX        83     91       {ECO:0000244|PDB:5J0A}.
FT   STRAND      100    105       {ECO:0000244|PDB:5J0A}.
FT   STRAND      108    115       {ECO:0000244|PDB:5J0A}.
FT   STRAND      120    122       {ECO:0000244|PDB:5J0A}.
FT   HELIX       123    131       {ECO:0000244|PDB:5J0A}.
FT   TURN        132    134       {ECO:0000244|PDB:5J0A}.
FT   HELIX       140    159       {ECO:0000244|PDB:5J0A}.
FT   HELIX       170    172       {ECO:0000244|PDB:5J0A}.
FT   STRAND      173    176       {ECO:0000244|PDB:5J0A}.
FT   TURN        177    180       {ECO:0000244|PDB:5J0A}.
FT   STRAND      181    184       {ECO:0000244|PDB:5J0A}.
FT   STRAND      189    192       {ECO:0000244|PDB:5J0A}.
FT   HELIX       210    212       {ECO:0000244|PDB:5J0A}.
FT   HELIX       215    217       {ECO:0000244|PDB:5J0A}.
FT   STRAND      219    221       {ECO:0000244|PDB:5J0A}.
FT   HELIX       227    242       {ECO:0000244|PDB:5J0A}.
FT   STRAND      250    252       {ECO:0000244|PDB:5J0A}.
FT   TURN        254    256       {ECO:0000244|PDB:5J0A}.
FT   HELIX       263    265       {ECO:0000244|PDB:5J0A}.
FT   HELIX       268    274       {ECO:0000244|PDB:5J0A}.
FT   TURN        283    285       {ECO:0000244|PDB:5J0A}.
FT   HELIX       291    300       {ECO:0000244|PDB:5J0A}.
FT   HELIX       305    307       {ECO:0000244|PDB:5J0A}.
FT   HELIX       311    319       {ECO:0000244|PDB:5J0A}.
SQ   SEQUENCE   322 AA;  36085 MW;  6BF55789BC204ABE CRC64;
     MEGISNFKTP SKLSEKKKSV LCSTPTINIP ASPFMQKLGF GTGVNVYLMK RSPRGLSHSP
     WAVKKINPIC NDHYRSVYQK RLMDEAKILK SLHHPNIVGY RAFTEANDGS LCLAMEYGGE
     KSLNDLIEER YKASQDPFPA AIILKVALNM ARGLKYLHQE KKLLHGDIKS SNVVIKGDFE
     TIKICDVGVS LPLDENMTVT DPEACYIGTE PWKPKEAVEE NGVITDKADI FAFGLTLWEM
     MTLSIPHINL SNDDDDEDKT FDESDFDDEA YYAALGTRPP INMEELDESY QKVIELFSVC
     TNEDPKDRPS AAHIVEALET DV
//
